Is Big Data Eclipsing the Role of Randomized Controlled Trials?

Renowned Researchers and Health Policy Experts Weigh In

Boston, MA—May 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted its third and final plenary session this morning focusing on the usefulness of big data in health care policy decisions. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

What Can We Learn From Global Health Care Systems?

A Look at Health Care Systems from Around the World

Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a number of sessions at its 22nd Annual International Conference in Boston, MA, USA that focused on the health care systems from different countries. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

Panel Explores Issue of Real-World Evidence to Inform Health Policies for Medical Devices

Boston, MA—May 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held an afternoon session at its 22nd Annual International Meeting in Boston, MA, USA that explored the use of real-world evidence to help inform health policies for medical devices. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

Best Podium and Poster Presentations Awarded at ISPOR 22nd Annual International Meeting

Boston, MA—May 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recognized the Best Podium and Poster Presentation Awardees at its 22nd Annual International Meeting today in Boston, MA, USA. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: ,

ISPOR Presents 2017 Scientific and Leadership Awards

Honorees Recognized for Excellence in HEOR at ISPOR’s 22nd Annual International Meeting

Boston, MA—May 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recognized honorees of the ISPOR Awards Program at its 22nd Annual International Meeting in Boston, MA, USA this week. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

Developing and Paying for Gene Therapies: How to Measure Value?

Boston, MA—May 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a session this morning at its 22nd Annual International Meeting in Boston, MA, USA that examined the issue of developing and paying for gene therapies. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

New Methodological Approaches to Assess Value of Immuno-Oncology Therapies

Boston, MA—MAY 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a morning session at its 22nd Annual International Meeting in Boston, MA, USA that examined cost-effectiveness models for innovative oncology treatments. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , ,

The 21st Century Cures Act: Considering the Implications

Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held several sessions at its 22nd Annual International Meeting in Boston, MA, USA this afternoon that discussed regulatory and health policy implications of the 21st Century Cures Act. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: ,

Short- and Long-Term Impact of Medicare Negotiating Drug Prices: A Critical Look at the Policy Proposals

Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a session that explored the economic impact of Medicare directly negotiating drug prices for enrollees. The session was held this afternoon at ISPOR’s 22nd Annual International Meeting in Boston, MA, USA. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , ,

The Power of Social Network Interventions on Population Health

Dr. Nicholas Christakis Presented Research on How Social Contagion Interventions Could Impact Health Care
 

Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its second plenary session this morning at its 22nd Annual International Meeting in Boston, MA, USA. The plenary, Social Network Interventions and Population Health, highlighted the research of Nicholas A. Christakis, MD, PhD, MPH, Sol Goldman Professor, Social and Natural Science, Co-Director, Yale Institute for Network Science, Yale University, New Haven, CT, USA. The plenary was moderated by Shelby D. Reed, PhD, RPh, Professor, Duke University, Durham, NC, USA and ISPOR President-Elect.   Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , ,